Advances in Therapy

, Volume 24, Issue 2, pp 319–325 | Cite as

Effects of alendronate sodium therapy on carotid intima media thickness in postmenopausal women with osteoporosis

  • Tuncay Delibasi
  • Rifat Emral
  • Murat F. Erdogan
  • Nuri Kamel


Osteoporosis and cardiovascular disease are major health problems that lead to morbidity and mortality. Bisphosphonates are among the drugs used most frequently worldwide to treat osteoporosis, especially in older women. B-mode ultrasonography has recently become a valuable tool for early diagnosis of atherosclerotic disease because of its ability to measure carotid artery intima media thickness (CIMT). The purpose of the present study was to investigate whether alendronate sodium therapy has an effect on CIMT in postmenopausal women with osteoporosis. A total of 71 postmenopausal women with osteoporosis were evaluated before and after they began taking alendronate sodium; follow-up was provided for an average of 13±2 mo. Osteoporosis was diagnosed with the use of dual-energy x-ray absorptiometry, and therapy with alendronate sodium was begun at a dose of 70 mg/wk. For CIMT, B-mode ultrasonography was performed on the right and left middle and distal main carotid arteries. Before alendronate sodium therapy was initiated, the average CIMT value was 0.734±0.121 mm; after therapy, the average CIMT was 0.712±0.111 mm. This difference was not confirmed to be statistically significant. Treatment of osteoporosis does not seem to have an effect on CIMT, which is an early marker of atherosclerosis.


bisphosphonate alendronate sodium carotid intimamedia thickness osteoporosis postmenopausal women 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hill AJ, Goldin JG, Gjertson D, et al. Progression of coronary artery calcification in patients taking alendronate for osteoporosis.Acad Radiol. 2002; 9: 1148–1152.PubMedCrossRefGoogle Scholar
  2. 2.
    Lusis AJ. Atherosclerosis.Nature. 2000; 407: 233–241.PubMedCrossRefGoogle Scholar
  3. 3.
    Mautner GC, Mautner SL, Froehlich J, et al. Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation.Radiology. 1994; 192: 619–623.PubMedGoogle Scholar
  4. 4.
    Bostrom K, Demer LL. Regulatory mechanisms in vascular calcification.Crit Rev Eukaryot Gene Expr. 2000; 10: 151–158.PubMedGoogle Scholar
  5. 5.
    Hamerman D. Osteoporosis and atherosclerosis: biological linkages and the emergence of dualpurpose therapies.QJM. 2005; 98: 467–484.PubMedCrossRefGoogle Scholar
  6. 6.
    Tanko LB, Bagger YZ, Christiansen C. Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women.Calcif Tissue Int. 2003; 73: 15–20.PubMedCrossRefGoogle Scholar
  7. 7.
    Parhami F. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor?Prostaglandins Leukot Essent Fatty Acids. 2003; 68: 373–378.PubMedCrossRefGoogle Scholar
  8. 8.
    Rosenblum IY, Flora L, Eisenstein R. The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis.Atherosclerosis. 1975; 22: 411–424.PubMedCrossRefGoogle Scholar
  9. 9.
    Kramsch DM, Chan CT. The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits.Circ Res. 1978; 42: 562–571.PubMedGoogle Scholar
  10. 10.
    Kramsch DM, Aspen AJ, Rozler LJ. Atherosclerosis: prevention by agents not affecting abnormal levels of blood lipids.Science. 1981; 213: 1511–1512.PubMedCrossRefGoogle Scholar
  11. 11.
    Ylitalo R, Oksala O, Yla-Herttuala S, Ylitalo P. Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits.J Lab Clin Med. 1994; 123: 769–776.PubMedGoogle Scholar
  12. 12.
    Shimshi M, Abe E, Fisher EA, Zaidi M, Fallon JT. Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice.Biochem Biophys Res Commun. 2005; 328: 790–793.PubMedCrossRefGoogle Scholar
  13. 13.
    Tanko LB, Qin G, Alexandersen P, Bagger YZ, Christiansen C. Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women.Osteoporos Int. 2005; 16: 184–190.PubMedCrossRefGoogle Scholar
  14. 14.
    Ylitalo R. Bisphosphonates and atherosclerosis.Gen Pharmacol. 2000; 35: 287–296.PubMedGoogle Scholar
  15. 15.
    O’Leary DH, Polak JF. Intima-media thickness: a tool for atherosclerosis imaging and event prediction.Am J Cardiol. 2002; 90: 18L-21L.PubMedCrossRefGoogle Scholar
  16. 16.
    Allan PL, Mowbray PI, Lee AJ, Fowkes FG. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study.Stroke. 1997; 28: 348–353.PubMedGoogle Scholar
  17. 17.
    Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. JIntern Med. 1991; 229: 225–231.PubMedCrossRefGoogle Scholar
  18. 18.
    Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction: a noninvasive method to predict severity of coronary atherosclerosis.Circulation. 1989; 80: 78–86.PubMedGoogle Scholar
  19. 19.
    Kawagishi T, Nishizawa Y, Konishi T, et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia.Kidney Int. 1995; 48: 820–826.PubMedCrossRefGoogle Scholar
  20. 20.
    Kawamori R, Yamasaki Y, Mastushima H, et al. Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries.Diabetes Care. 1992; 15: 1290–1294.PubMedCrossRefGoogle Scholar
  21. 21.
    Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis.Arthritis Rheum. 2002; 46: 1489–1497.PubMedCrossRefGoogle Scholar
  22. 22.
    Lekakis JP, Papamichael CM, Alevizaki MK, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values.Thyroid. 1997; 7: 411–414.PubMedCrossRefGoogle Scholar
  23. 23.
    Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a populationbased ultrasonography study.Atherosclerosis. 1990; 81: 33–40.PubMedCrossRefGoogle Scholar
  24. 24.
    Simons PC, Algra A, Bots ML, Grobbee DE, van der Graaf Y. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease) study.Circulation. 1999; 100: 951–957.PubMedGoogle Scholar
  25. 25.
    Wofford JL, Kahl FR, Howard GR, McKinney WM, Toole JF, Crouse Jr III. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis.Arterioscler Thromb. 1991; 11: 1786–1794.PubMedGoogle Scholar
  26. 26.
    Koshiyama H, Nakamura Y, Tanaka S, Minamikawa J. Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes.J Clin Endocrinol Metab. 2000; 85: 2793–2796.PubMedCrossRefGoogle Scholar
  27. 27.
    NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy.JAMA. 2001; 285: 785–795.CrossRefGoogle Scholar
  28. 28.
    Lehmann ED, Riley WA, Clarkson P, Gosling RG. Non-invasive assessment of cardiovascular disease in diabetes mellitus.Lancet. 1997; 350: SI14-SI19.PubMedGoogle Scholar
  29. 29.
    Minamikawa J, Yamauchi M, Tanaka S, Koshiyama H. Carotid arterial intimal-medial thickening and plaque formation in NIDDM.Diabetes Care. 1998; 21: 323–324.PubMedGoogle Scholar
  30. 30.
    Demer LL. Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids.Int J Epidemiol. 2002; 31: 737–741.PubMedCrossRefGoogle Scholar
  31. 31.
    Parhami F, Garfinkel A, Demer LL. Role of lipids in osteoporosis.Arterioscler Thromb Vasc Biol. 2000; 20: 2346–2348.PubMedGoogle Scholar
  32. 32.
    Tintut Y, Demer LL. Recent advances in multifactorial regulation of vascular calcification.Curr Opin Lipidol. 2001; 12: 555–560.PubMedCrossRefGoogle Scholar
  33. 33.
    Montalcini T, Emanuele V, Ceravolo R, et al. Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women.Am J Cardiol. 2004; 94: 266–269.PubMedCrossRefGoogle Scholar
  34. 34.
    Uyama O, Yoshimoto Y, Yamamoto Y, Kawai A. Bone changes and carotid atherosclerosis in postmenopausal women.Stroke. 1997; 28: 1730–1732.PubMedGoogle Scholar
  35. 35.
    Tintut Y, Morony S, Demer LL. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo.Arterioscler Thromb Vasc Biol. 2004; 24: e6-e10.PubMedCrossRefGoogle Scholar
  36. 36.
    Gupta G, Aronow WS. Atherosclerotic vascular disease may be associated with osteoporosis or osteopenia in postmenopausal women: a preliminary study.Arch Gerontol Geriatr. 2006; 43: 285–288.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science and Business Media and LLC 2007

Authors and Affiliations

  • Tuncay Delibasi
    • 1
  • Rifat Emral
    • 1
  • Murat F. Erdogan
    • 1
  • Nuri Kamel
    • 1
  1. 1.Department of Endocrinology and MetabolicDiseases Ankara University School of MedicineAnkaraTurkey

Personalised recommendations